Genetic Testing – Ayass BioScience, LLC

Genetic Testing – Ayass BioScience, LLC

Ayass BioScience, LLC – Contact Information

8501 Wade Blvd. Bldg 9, Frisco, TX 750934

Phone: 972-668-6005

Fax: 972-668-6720

Larisa

About Larisa

This author has not yet filled in any details.
So far Larisa has created 58 blog entries.

Alzheimer Proteomics! The Road for New Early Detection!

By | December 27th, 2016|Mass Spectrometry|

Mass spectrometry-based proteomics are used to identify biomarkers in Alzheimer's Disease (AD) and to establish how these biomarkers change in the brain during disease progression. The study of peptides, proteomics [...]

CYP Genetic (Genotyping) Testing! Precision Medicine in Toxicology Drug Interactions and Labeling

By | December 27th, 2016|Next Generation Sequencing, Toxicology|

Cytochrome P450 (CYP450) tests help determine how your body processes (metabolizes) or responds to medications. We look for variations in cytochrome P450 genes that can affect the breakdown of medications. Depending [...]

Mass Spectrometry – Proteomics – Metabolomics – for Disease – Specific Biomarkers

By | December 22nd, 2016|Genetic Testing, Mass Spectrometry, Next Generation Sequencing, Research|

The Proteomics studies that corroborate Metabolomics findings are the next generation of laboratory testing using the Mass Spectrometry, a key technology for targeted protein and metabolite identification and quantification. This assay [...]

Solid Tumor NGS DNA Testing!

By | December 16th, 2016|Genetic Testing, Next Generation Sequencing, Solid Tumor|

At Ayass BioScience, we use high-throughput Next Generation Sequencing technology to sequence cancer patients' solid tumor DNA (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer). Targeted sequencing of tumor DNA across our [...]

Your DNA Doesn’t Tell You the Whole Story

By | December 12th, 2016|Genetic Testing, Next Generation Sequencing|

We inherit DNA from our parents - but it only part of equation. Epigenetics is alteration in gene expression rather then the genetic code that affects genetics. DNA methylation, histone [...]

ctDNA Detection – CLIA Compliant Lab Developed Test!

By | December 8th, 2016|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing|

Ayass BioScience Circulating Tumor DNA (ctDNA) Assay is CLIA Compliant Lab Developed Test for Clinical Practice. Ayass BioScience ctDNA detects low levels of circulating tumor DNA (ctDNA) in the blood stream [...]

“Liquid Biopsy” for ctDNA Detection – A New Generation of Cancer Biomarker!

By | November 30th, 2016|Circulating Tumor DNA, Next Generation Sequencing|

Detecting low levels of circulating tumor DNA (ctDNA) in the blood stream using NGS technology is a minimally invasive method to detect the presence of tumor DNA that is shed [...]

Wishing You Good Health and a Very Happy and Blessed Thanksgiving!

By | November 22nd, 2016|News from Ayass BioScience|

Thanksgiving reminds us to give thanks and to count our blessings. Each day we are thankful for dark nights that turn into beautiful mornings, for friendships that turn into family [...]

The Aptamer Project at Ayass Bioscience – Staying on the Cutting Edge of Science!

By | November 11th, 2016|Uncategorized|

The Aptamer project at Ayass Bioscience aims to identify Aptamers for in vitro diagnosis by detecting biomarkers associated with Cardiovascular Disease. Call us with any questions you might have about [...]

Next Generation Sequencing of Solid Tumor DNA

By | November 8th, 2016|Breast Cancer, Genetic Testing, Next Generation Sequencing, Solid Tumor|

Precision medicine is personalized medical care based on the genetic profiles of patients. At Ayass BioScience, we use high-throughput Next Generation Sequencing technologies to sequence cancer patients' solid tumor DNA. [...]

Leukemia Genetic Testing

By | November 7th, 2016|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing|

Leukemia is a cancer of blood forming tissues, such as bone marrow. A quick comprehensive genetic test can be used to supplement common detection methods of leukemia, and assist in [...]

BRCA1 and BRCA2 (BReast CAncer) are the best-known genes linked to breast cancer

By | November 3rd, 2016|Breast Cancer, Circulating Tumor DNA, Genetic Testing|

People who have a BRCA's mutation have much higher-than-average risk of developing breast cancer in both genders and ovarian cancer in women. With a blood test at Ayass BioScience, we [...]